High resolution X-ray structure of potent anti-HIV pokeweed antiviral protein-III

Biochemical Pharmacology

Volumn 65, Issue 10, 2003, Pages 1709-1717

  Kurinov, Igor V ^a   Uckun, Fatih M ^a  

^a Parker Hughes Cancer Center   (United States)

Author keywords

Anti HIV protein; Pokeweed antiviral protein; Ribosome inactivation; X ray structure

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ARGININE; ARGININE 175; GLUTAMINE; GLUTAMINE 172; POKEWEED ANTIVIRAL PROTEIN I; POKEWEED ANTIVIRAL PROTEIN III; RIBOSOME INACTIVATING PROTEIN; RNA; TYROSINE; TYROSINE 117; TYROSINE 69; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ANALYTICAL PARAMETERS; ARTICLE; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR MODEL; NONHUMAN; POKEWEED; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; RNA BINDING; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS; SURFACE PROPERTY; X RAY ANALYSIS;

EID: 0038392825     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00144-8     Document Type: Article

References (46)

1. Irvin J.D. Pokeweed antiviral protein. Pharmacol. Ther. 21:1983;371-387.
2. Barbieri L., Batelli M.G., Stirpe F. Ribosome-inactivating proteins from plants. Biochim. Biophys. Acta. 1154:1993;237-282.
3. Irvin J.D., Kelly T., Robertus J.D. Purification and properties of a second antiviral protein from Phytolacca americana which inactivates eukaryotic ribosomes. Arch. Biochem. Biophys. 200:1980;418-425.
4. Monzingo A.F., Collins E.J., Ernst S.R., Irvin J.D., Robertus J.D. The 2.5 Å structure of pokeweed antiviral protein. J. Mol. Biol. 233:1993;705-715.
5. Kurinov I.V., Myers D.E., Irvin J.D., Uckun F.M. X-ray crystallographic analysis of the structural basis for the interactions of pokeweed antiviral protein with its active site inhibitor and ribosomal RNA substrate analogs. Protein Sci. 8:1999;1765-1772.
6. Li H.M., Zeng Z.H., Hu Z., Wang D.C. Crystallization and preliminary crystallographic analyses of pokeweed antiviral protein from seeds. Acta Crystallogr. D Biol. Crystallogr. 54:1998;137-139.
7. Poyet J.L., Radom J., Hoeveler A. Isolation and characterization of a cDNA clone encoding the pokeweed antiviral protein II from Phytolacca americana and its expression in E. coli. FEBS Lett. 347:1994;268-272.
8. Endo Y., Tsurugi K. The RNA N-glycosidase activity of ricin A-chain. The characteristics of the enzymatic activity of ricin A-chain with ribosomes and with rRNA. J. Biol. Chem. 263:1988;8735-8739.
9. Gessner S.L., Irvin J.D. Inhibition of elongation factor 2-dependent translocation by the pokeweed antiviral protein and ricin. J. Biol. Chem. 255:1980;3251-3253.
10. Barbieri L., Valbonesi P., Bonora E., Gorini P., Bolognesi A., Stirpe F. Polynucleotide:adenosine glycosidase activity of ribosome-inactivating proteins: effect on DNA RNA and poly(A). Nucleic Acids Res. 25:1997;518-522.
11. Nicolas E., Beggs J.M., Haltiwanger B.M., Taraschi T.F. A new class of DNA glycosylase/apurinic/apyrimidinic lyases that act on specific adenines in single-stranded DNA. J. Biol. Chem. 273:1988;17216-17220.
12. Wang P., Tumer N.E. Pokeweed antiviral protein cleaves double-stranded supercoiled DNA using the same active site required to depurinate rRNA. Nucleic Acids Res. 27:1999;1900-1905.
13. Rajamohan F., Venkatachalam T.K., Irvin J.D., Uckun F.M. Pokeweed antiviral protein isoforms PAP-I, PAP-II, and PAP-III depurinate RNA of human immunodeficiency virus (HIV)-1. Biochem. Biophys. Res. Commun. 260:1999;453-458.
14. Rajamohan F., Kurinov I.V., Venkatachlam T.K., Uckun F.M. Deguanylation of human immunodeficiency virus (HIV-1) RNA by recombinant pokeweed antiviral protein. Biochem. Biophys. Res. Commun. 263:1999;419-424.
15. Kurinov I.V., Rajamohan F., Venkatachlam T.K., Uckun F.M. X-ray crystallographic analysis of the structural basis for the interaction of pokeweed antiviral protein with guanine residues of ribosomal RNA. Protein Sci. 8:1999;2399-2405.
16. Aron G.M., Irvin J.D. Inhibition of herpes simplex virus multiplication by the pokeweed antiviral protein. Antimicrob. Agents Chemother. 17:1980;1032-1033.
17. Tomlinson J.A., Walker V.M., Flewett T.H., Barclay G.R. The inhibition of infection by cucumber mosaic virus and influenza virus by extracts from Phytolacca americana. J. Gen. Virol. 22:1974;225-232.
18. Gehrz RC, Wilson C, Eckhardt J, Myers DE, Irvin JD, Uckun FM. Treatment of human cytomegalovirus (HCMV) with noval antiviral immunoconjugates. In: Landini MP, editor. Progress in cytomegalovirus research. New York: Elsevier; 1991. p. 353-6.
19. + cells by monoclonal antibodies. Nature. 347:1990;92-95.
20. Lee-Huang S., Huang P.L., Huang P.L., Bourinbaiar A.S., Chen H.C., Kung H.F. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. Proc. Natl. Acad. Sci. U.S.A. 92:1995;8818-8822.
21. Au T.K., Collins R.A., Lam T.L., Ng T.B., Fong W.P., Wan D.C. The plant ribosome inactivating proteins luffin and saporin are potent inhibitors of HIV-1 integrase. FEBS Lett. 471:2000;169-172.
22. Bonness M.S., Ready M.P., Irvin J.D., Mabry T.J. Pokeweed antiviral protein inactivates pokeweed ribosomes implications for the antiviral mechanism. Plant J. 5:1994;173-183.
23. Chaddock J.A., Lord J.M., Hartley M.R., Roberts L.M. Pokeweed antiviral protein (PAP) mutations which permit E. coli growth do not eliminate catalytic activity towards prokaryotic ribosomes. Nucleic Acids Res. 22:1994;1536-1540.
24. Hur Y., Hwang D.J., Zoubenko O., Coetzer C., Uckun F.M., Tumer N.E. Isolation and characterization of pokeweed antiviral protein mutations in Saccharomyces cerevisiae: identification of residues important for toxicity. Proc. Natl. Acad. Sci. U.S.A. 92:1995;8448-8452.
25. Tumer N.E., Hwang D.J., Bonness M. C-terminal deletion mutant of pokeweed antiviral protein inhibits viral infection but does not depurinate host ribosomes. Proc. Natl. Acad. Sci. U.S.A. 94:1997;3866-3871.
26. Tumer N.E., Parikh B.A., Li P., Dinman J.D. The pokeweed antiviral protein specifically inhibits Ty1-directed +1 ribosomal frameshifting and retrotransposition in Saccharomyces cerevisiae. J. Virol. 72:1998;1036-1042.
27. Irvin J.D., Uckun F.M. Pokeweed antiviral protein: ribosome inactivation and therapeutic applications. Pharmacol. Ther. 55:1992;279-302.
28. Rajamohan F., Pugmire M.J., Kurinov I.V., Uckun F.M. Modeling and alanine scanning mutagenesis studies of recombinant pokeweed antiviral protein. J. Biol. Chem. 275:2000;3382-3390.
29. Myers D.E., Irvin J.D., Smith R.S., Kuebelbeck V.M., Uckun F.M. Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials. J. Immunol. Methods. 136:1991;221-237.
30. Rypniewski W.R., Holden H.M., Rayment I. Structural consequences of reductive methylation of lysine residues in hen egg white lysozyme: an X-ray analysis at 1.8 Å resolution. Biochemistry. 32:1993;9851-9858.
31. Means G.E., Feeney R.E. Reductive alkylation of amino groups in proteins. Biochemistry. 7:1968;2192-2201.
32. Kurinov I.V., Mao C., Irvin J.D., Uckun F.M. X-ray crystallographic analysis of pokeweed antiviral protein-II after reductive methylation of lysine residues. Biochem. Biophys. Res. Commun. 275:2000;549-552.
33. Irvin J.D., Aron G.M. Chemical modifications of pokeweed antiviral protein: effects upon ribosome inactivation, antiviral activity and cytotoxicity. FEBS Lett. 148:1982;127-130.
34. Otwinnowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-325.
35. Matthews B.W. Solvent content of protein crystals. J. Mol. Biol. 33:1968;491-497.
36. Brunger AT. 1992 X-PLOR (version 3.1) Manual. New Haven, CT: Yale University Press; 1992.
37. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., Read R.J., Rice L.M., Simonson T., Warren G.L. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54:1998;905-921.
38. InsightII. User guide. San Diego, CA: Molecular Simulations Inc.; 1991.
39. Sack J.S. CHAIN: a crystallographic modeling program. J. Mol. Graph. 6:1988;224-225.
40. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:1993;283-291.
41. Katzin B.J., Collins E.J., Robertus J.D. Structure of ricin A-chain at 2.5 Å Proteins. 10:1991;251-259.
42. Zhou K., Fu Z., Chen M., Lin Y., Pan K. Structure of trichosanthin at 1.88 Å resolution. Proteins. 19:1994;4-13.
43. Carson M. Ribbons Methods Enzymol. 277:1997;493-505.
44. Kim Y., Robertus J.D. Analysis of several key active site residues of ricin A chain by mutagenesis and X-ray crystallography. Protein Eng. 5:1992;775-779.
45. Huang Q., Liu S., Tang Y., Jin S., Wang Y. Studies on crystal structures active-centre geometry and depurinating mechanism of two ribosome-inactivating proteins. Biochem. J. 309:1995;285-298.
46. Nicholls A., Sharp K.A., Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins. 11:1991;281-296.